Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial.

Lian F, Li G, Chen X, Wang X, Piao C, Wang J, Hong Y, Ba Z, Wu S, Zhou X, Lang J, Liu Y, Zhang R, Hao J, Zhu Z, Li H, Fang Liu H, Cao A, Yan Z, An Y, Bai Y, Wang Q, Zhen Z, Yu C, Wang CZ, Yuan CS, Tong X.

J Clin Endocrinol Metab. 2014 Feb;99(2):648-55. doi: 10.1210/jc.2013-3276. Epub 2014 Jan 16.

PMID:
24432995
2.

Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.

Grant SJ, Chang DH, Liu J, Wong V, Kiat H, Bensoussan A.

BMC Complement Altern Med. 2013 May 14;13:104. doi: 10.1186/1472-6882-13-104.

3.

The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.

Sun X, Guo L, Shang H, Ren M, Wang Y, Huo D, Lei X, Wang H, Zhai J.

Trials. 2015 Nov 3;16:496. doi: 10.1186/s13063-015-0990-9.

4.

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.

Marbury TC, Schwartz S, Rosenberg MA, Jariwala N, Becker RH, Johnston PS.

Exp Clin Endocrinol Diabetes. 2008 May;116(5):282-8. doi: 10.1055/s-2007-1022521.

PMID:
18484560
5.
7.

Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.

Bone HG, Lindsay R, McClung MR, Perez AT, Raanan MG, Spanheimer RG.

J Clin Endocrinol Metab. 2013 Dec;98(12):4691-701. doi: 10.1210/jc.2012-4096. Epub 2013 Sep 20.

PMID:
24057294
8.

Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.

Eriksson JG, Lehtovirta M, Ehrnström B, Salmela S, Groop L.

J Intern Med. 2006 Jun;259(6):553-60.

9.

Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance.

Shi YL, Liu WJ, Zhang XF, Su WJ, Chen NN, Lu SH, Wang LY, Shi XL, Li ZB, Yang SY.

Chin Med J (Engl). 2016 Oct 5;129(19):2281-6. doi: 10.4103/0366-6999.190676.

10.

[Alpha-glucosidase inhibitor for the prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese subjects with impaired glucose tolerance].

Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K.

Nihon Rinsho. 2009 Sep;67(9):1821-5. Japanese.

PMID:
19768922
12.

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K; Voglibose Ph-3 Study Group.

Lancet. 2009 May 9;373(9675):1607-14. doi: 10.1016/S0140-6736(09)60222-1. Epub 2009 Apr 22.

PMID:
19395079
13.

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.

Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T.

Stroke. 2004 May;35(5):1073-8. Epub 2004 Apr 8.

14.

JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial.

Cao H, Ren M, Guo L, Shang H, Zhang J, Song Y, Wang H, Wang B, Li X, Hu J, Wang X, Wang D, Chen J, Li S, Chen L.

Trials. 2010 Mar 10;11:27. doi: 10.1186/1745-6215-11-27.

15.

Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial.

Fang Z, Zhao J, Shi G, Shu Y, Ni Y, Wang H, Ding L, Lu R, Li J, Zhu X, Cheng S, Zhang X, Liu Y, Wang J, Luo Y, Fan Q, Guo C, Jiang T, Wu Q, Fan L, Ling H, Cui L, Luo Y, Yang H, Anderson RM.

Complement Ther Med. 2014 Oct;22(5):842-50. doi: 10.1016/j.ctim.2014.08.004. Epub 2014 Aug 12.

16.

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

Antonucci T, Whitcomb R, McLain R, Lockwood D, Norris RM.

Diabetes Care. 1997 Feb;20(2):188-93. Erratum in: Diabetes Care 1998 Apr;21(4):678.

PMID:
9118772
18.

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA.

Diabetes Metab. 2009 Nov;35(5):385-91. doi: 10.1016/j.diabet.2009.03.005. Epub 2009 Aug 7.

PMID:
19665415
19.

Effect of metformin on patients with impaired glucose tolerance.

Li CL, Pan CY, Lu JM, Zhu Y, Wang JH, Deng XX, Xia FC, Wang HZ, Wang HY.

Diabet Med. 1999 Jun;16(6):477-81.

PMID:
10391395
20.

Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose.

Grant SJ, Bensoussan A, Chang D, Kiat H, Klupp NL, Liu JP, Li X.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006690. doi: 10.1002/14651858.CD006690.pub2. Review.

Supplemental Content

Support Center